These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6215823)

  • 1. Diabetes mellitus in a mongoloid child with chronic diphenylhydantoin therapy.
    Pavone L; Mazzone D; Grasso S; Prato F; Raiti S
    Acta Paediatr Scand; 1982 May; 71(3):523-4. PubMed ID: 6215823
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects of phenytoin given for late-onset seizures in adults with Down syndrome.
    Tsiouris JA; Patti PJ; Tipu O; Raguthu S
    Neurology; 2002 Sep; 59(5):779-80. PubMed ID: 12221182
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric review: Transient diabetes mellitus secondary to diphenylhydantoin intoxication.
    Stansell PE; Schedewie HK; Elders MJ; Fiser RH; Bornhofen JH; MacLeod VO
    J Ark Med Soc; 1979 Oct; 76(5):209-10. PubMed ID: 159893
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric drug information: phenytoin in anticonvulsant therapy.
    Robinson LA
    Pediatr Nurs; 1979; 5(3):57-8. PubMed ID: 255226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myasthenic syndrome following long-term diphenylhydantoin therapy].
    Milonas J; Kountouris D; Scheer E
    Nervenarzt; 1983 Aug; 54(8):437-8. PubMed ID: 6413870
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated serum alkaline phosphatase levels in epilepsy during diphenylhydantoin therapy.
    Kazamatsuri H
    N Engl J Med; 1970 Dec; 283(25):1411-2. PubMed ID: 5481765
    [No Abstract]   [Full Text] [Related]  

  • 8. [Scleroderma developing during treatment of ictal stupor with diphenylhydantoin].
    Kashiwazaki S; Goto T; Okada J; Tadenuma T; Tazaki Y
    Ryumachi; 1974 Oct; 14(3):220-8. PubMed ID: 4450153
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development.
    Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082
    [No Abstract]   [Full Text] [Related]  

  • 10. Diphenylhydantoin and epilepsy management.
    Easton JD
    Ann Intern Med; 1972 Sep; 77(3):421-3. PubMed ID: 5053732
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy].
    Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G
    Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of diphenylhydantoin.
    Simpson JF
    Ann Intern Med; 1973 Feb; 78(2):305-6. PubMed ID: 4683770
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated malignant lymphoma of the jejunum and long-term diphenylhydantoin therapy.
    Rubinstein I; Langevitz P; Shibi G
    Oncology; 1985; 42(2):104-6. PubMed ID: 3887259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.
    Gallagher BB; Baumel IP; Mattson RH; Woodbury SG
    Neurology; 1973 Feb; 23(2):145-9. PubMed ID: 4734509
    [No Abstract]   [Full Text] [Related]  

  • 15. The gingival hyperplasia resulting from diphenylhydantoin in children and adults.
    Matsumoto K; Nakagawa K; Kaneko Z
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):369-71. PubMed ID: 1176242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenylhydantoin-induced cerebellar degeneration.
    Selhorst JB; Kaufman B; Horwitz SJ
    Arch Neurol; 1972 Nov; 27(5):453-5. PubMed ID: 4342796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver damage after long-term administration of phenylethylbarbituric acid and diphenylhydantoin].
    Cammann R; Wiechert P
    Cesk Neurol Neurochir; 1977 Mar; 40(2):73-7. PubMed ID: 852043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diphenylhydantoin inducing a lupus erythematosus-like syndrome].
    Rybicka K; Wierzchowiecki M
    Pol Tyg Lek; 1977 Aug; 32(33):1269-71. PubMed ID: 905167
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Diphenylhydantoin and blood dyscrasias.
    Livingston S; Pauli LL
    JAMA; 1974 Oct; 230(2):211-2. PubMed ID: 4479170
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy.
    Staberg B; Hueg B
    Acta Derm Venereol; 1985; 65(6):553-5. PubMed ID: 2420126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.